Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder

NCT05529901 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT05529901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05529901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Lead sponsor
W.L.Gore & Associates
Phase
Observational
Overall status
Active, not recruiting
Start date
October 3, 2022
Completion date
August 31, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryptogenic stroke, pfo - patent foramen ovale, stroke, tia